- News
- Astrazeneca
Tag:
Astrazeneca
-
AstraZeneca has warned that Germany risks losing access to new medicines if it moves ahead with plans to tighten controls on pharmaceutical spending, according to comments by the company’s CEO.21 Apr 2026-16:57
-
-
Shares in Roche dropped more than 5% on March 9 after the Swiss pharmaceutical company announced that its experimental oral breast cancer drug giredestrant failed to show effectiveness in newly diagnosed patients.09 Mar 2026-13:54
-
-
Shares of AstraZeneca, the UK’s largest drugmaker, will begin trading on the New York Stock Exchange on Monday following a listing upgrade that replaces its American Depositary Receipts previously traded on Nasdaq.02 Feb 2026-13:55
-
-
British pharmaceutical giant AstraZeneca announced on Thursday that it will invest $15 billion in China by 2030 to expand its medicines manufacturing and research footprint, coinciding with a visit to Beijing by UK Prime Minister Keir Starmer.29 Jan 2026-15:59
-
-
Swiss pharmaceutical giants Novartis and Roche have expressed support for U.S. efforts to lower drug prices and are working with the Trump administration on potential pricing agreements. The discussions follow a trend of recent deals by Pfizer, AstraZeneca, Eli Lilly, and Novo Nordisk to reduce costs for Medicare, Medicaid, and cash-paying patients.18 Dec 2025-13:35
-
-
British pharmaceutical giant AstraZeneca announced a sharp rise in quarterly profit on Thursday, driven by strong sales of cancer treatments and growth in its U.S. business.
06 Nov 2025-17:53 -
-
British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States amid a looming deadline of ramped-up tariffs from Washington.22 Jul 2025-16:15
-
-
-
-
-
-